Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 21 - Issue 8 - August, 2009

Feature

Review
Clinical Insights into the Use of Embolic Protection Devices during Lower Extremity Peripheral Vascular Interventions
08/17/2009
*David E. Allie, MD, *Agostino Ingraldi, MD, §Raghotham R. Patlola, MD, §Chris J. Hebert, RT(R), RCIS, §Craig M. Walker, MD
*David E. Allie, MD, *Agostino Ingra...
ABSTRACT: The use of embolic protection devices (EPD) during lower extremity peripheral vascular interventions (PVI) remains controversial. We examine the current data and present our Louisiana experience with discussions regarding the...
ABSTRACT: The use of embolic protection devices (EPD) during lower extremity peripheral vascular interventions (PVI) remains controversial. We examine the current data and present our Louisiana experience with discussions regarding the...
ABSTRACT: The use of embolic...
08/17/2009
Journal of Invasive Cardiology
Review
Embolic Protection during Saphenous Vein Graft Interventions
08/17/2009
Subhash Banerjee, MD and Emmanouil S. Brilakis, MD, PhD
Subhash Banerjee, MD and Emmanouil S....
ABSTRACT: Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven...
ABSTRACT: Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven...
ABSTRACT: Stenting of saphenous...
08/17/2009
Journal of Invasive Cardiology
Review
Contemporary Review of Embolic Distal Protection Strategies in Carotid Artery Stenting
08/17/2009
Russell C. Lam, MD
Russell C. Lam, MD
ABSTRACT: Stroke is the third most common cause of death in the United States. Approximately 30% of all ischemic strokes are secondary to carotid artery disease. Carotid endarterectomy (CEA) is considered the gold standard for the treatment...
ABSTRACT: Stroke is the third most common cause of death in the United States. Approximately 30% of all ischemic strokes are secondary to carotid artery disease. Carotid endarterectomy (CEA) is considered the gold standard for the treatment...
ABSTRACT: Stroke is the third...
08/17/2009
Journal of Invasive Cardiology
Review
ADP Receptor-Blocker Thienopyridines: Chemical Structures, Mode of Action and Clinical Use. A Review
08/17/2009
*Mehrnoosh Hashemzadeh, PhD, ∞Sarah Goldsberry, MS, ∞Matthew Furukawa, BS, £Ali Khoynezhad, MD, *,§Mohammad Reza Movahed, MD, PhD
*Mehrnoosh Hashemzadeh, PhD, ‚àûSarah...
ABSTRACT: One of the major classes of adenosine diphosphate (ADP) receptor antagonists are thienopyridines. Thienopyridines compose a subcategory of antiplatelet medications, known as ADP receptor inhibitors, used commonly for the treatment...
ABSTRACT: One of the major classes of adenosine diphosphate (ADP) receptor antagonists are thienopyridines. Thienopyridines compose a subcategory of antiplatelet medications, known as ADP receptor inhibitors, used commonly for the treatment...
ABSTRACT: One of the major...
08/17/2009
Journal of Invasive Cardiology
Original Contribution
Initial Experience with the New Amplatzer® Duct Occluder II
08/17/2009
Jaspal Dua, MBBS, DCH, MRCPCH, MD, Massimo Chessa, MD, PhD, Luciane Piazza, MD, Diana Negura, MD, Angelo Micheletti, MD, Claudio Bussadori, MD, Gianfranco Butera, MD, PhD, Mario Carminati, MD
Jaspal Dua, MBBS, DCH, MRCPCH, MD, Ma...
ABSTRACT: Background. Different devices are used for trans-catheter occlusion of patent ductus arteriosus (PDA), each with its own limitations and complications. We report our initial single-center experience with the new Amplatzer® Duct...
ABSTRACT: Background. Different devices are used for trans-catheter occlusion of patent ductus arteriosus (PDA), each with its own limitations and complications. We report our initial single-center experience with the new Amplatzer® Duct...
ABSTRACT: Background. Different...
08/17/2009
Journal of Invasive Cardiology
Original Contribution
Comparison of Hydrophilic Guidewires Used in Endovascular Procedures
08/17/2009
Khusrow Niazi, MD, Falahat Farooqui, MD, Chandan Devireddy, MD, Gregory Robertson, MD, Richard E. Shaw, PhD
Khusrow Niazi, MD, Falahat Farooqui, ...
ABSTRACT: The development of hydrophilic guidewires has provided the vascular interventionalist with an important tool to more effectively deliver diagnostic and therapeutic equipment. Method. To determine whether significant variation in...
ABSTRACT: The development of hydrophilic guidewires has provided the vascular interventionalist with an important tool to more effectively deliver diagnostic and therapeutic equipment. Method. To determine whether significant variation in...
ABSTRACT: The development of...
08/17/2009
Journal of Invasive Cardiology
Original Contribution
Evaluation of the Efficacy and Safety of a Stent Covered with Biosynthetic Cellulose in a Rabbit Iliac Artery Model
08/17/2009
Ronaldo R. L. Bueno, MD, PhD, Jean-François Tanguay, MD, Fabio S. Brito, Jr., MD, PhD, Enio E. Guerios, MD, José C. Tarastchuk, MD, Pablo A. Sanches, PhD, Paulo M. Andrade, MD, Paulo F. Rossi, MD, PhD, Felipe L. Bueno, MD
Ronaldo R. L. Bueno, MD, PhD, Jean-Fr...
ABSTRACT: Objectives. We sought to test the efficacy and safety of the implantation of a stent covered with biosynthetic cellulose compared to a conventional bare-metal stent (BMS) in a rabbit iliac artery model. Background. Biosynthetic...
ABSTRACT: Objectives. We sought to test the efficacy and safety of the implantation of a stent covered with biosynthetic cellulose compared to a conventional bare-metal stent (BMS) in a rabbit iliac artery model. Background. Biosynthetic...
ABSTRACT: Objectives. We sought...
08/17/2009
Journal of Invasive Cardiology
Original Contribution
Decline in the Nationwide Trends in In-Hospital Mortality of Patients undergoing Multivessel Percutaneous Coronary Intervention
08/17/2009
a,bMohammad Reza Movahed, MD, PhD, bRadhakrishnan Ramaraj, MD,bM. Mazen Jamal, MD, MHSA, cMehrtash Hashemzadeh, MS
a,bMohammad Reza Movahed, MD, PhD, bR...
ABSTRACT: Background. Advances in the safety of percutaneous coronary interventions have been significant in recent years. The goal of this study was to evaluate any decline in the age-adjusted in-hospital mortality rate in patients...
ABSTRACT: Background. Advances in the safety of percutaneous coronary interventions have been significant in recent years. The goal of this study was to evaluate any decline in the age-adjusted in-hospital mortality rate in patients...
ABSTRACT: Background. Advances...
08/17/2009
Journal of Invasive Cardiology
Original Contribution
Clinical Utility of 3 French Infrapopliteal Intervention in the Setting of Critical Limb Ischemia
08/17/2009
Osami Kawarada, MD
Osami Kawarada, MD
ABSTRACT: Objectives. To evaluate the clinical utility of 3 Fr infrapopliteal intervention in critical limb ischemia (CLI) patients with isolated infrapopliteal artery disease (IPD). Background. There is considerable scope for the...
ABSTRACT: Objectives. To evaluate the clinical utility of 3 Fr infrapopliteal intervention in critical limb ischemia (CLI) patients with isolated infrapopliteal artery disease (IPD). Background. There is considerable scope for the...
ABSTRACT: Objectives. To...
08/17/2009
Journal of Invasive Cardiology

Insights

Commentary
When is Smaller Better?
08/17/2009
David M. Shavelle, MD
David M. Shavelle, MD
Vascular complications during endovascular intervention remain an important cause of the morbidity and mortality associated with the procedure. Risk factors for vascular complications include older age, location of the arteriotomy site and...
Vascular complications during endovascular intervention remain an important cause of the morbidity and mortality associated with the procedure. Risk factors for vascular complications include older age, location of the arteriotomy site and...
Vascular complications during...
08/17/2009
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

August 2009 Volume 21 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement